Search clinical trials for: HDREGN2810
Total 79 results
-
Regeneron PharmaceuticalsSanofiTerminatedAdvanced Non-Small Cell Lung CarcinomaUnited States, Belgium, France, Germany, Korea, Republic of, Poland, Spain, Taiwan, United Kingdom
-
Regeneron PharmaceuticalsSanofiTerminatedNon-small Cell Lung CancerUnited States, Italy, Lithuania
-
Regeneron PharmaceuticalsSanofiActive, not recruitingNon-small Cell Lung CancerUnited States, France, Korea, Republic of, Italy, Austria, China, Georgia, Greece, Ireland, Lithuania, Malaysia, Poland, Romania, Russian Federation, Slovakia, Thailand, Turkey, Ukraine
-
National Institute of Allergy and Infectious Diseases...Regeneron PharmaceuticalsTerminated
-
Regeneron PharmaceuticalsTerminatedCarcinoma, Non-Small-Cell LungUnited States
-
Regeneron PharmaceuticalsSanofiRecruitingBasal Cell Carcinoma | Cutaneous Squamous Cell CarcinomaUnited States
-
Regeneron PharmaceuticalsWithdrawnAdvanced MalignanciesUnited States
-
Regeneron PharmaceuticalsSanofiActive, not recruitingCutaneous Squamous Cell CarcinomaUnited States, Germany, Australia
-
Regeneron PharmaceuticalsSanofiNo longer availableCutaneous Squamous Cell Carcinoma
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Regeneron PharmaceuticalsRecruitingColorectal CancerUnited States
-
Regeneron PharmaceuticalsRecruitingMetastatic Castration-resistant Prostate Cancer (mCRPC) | Clear Cell Renal Cell Carcinoma (ccRCC)United States
-
University of MiamiRegeneron PharmaceuticalsWithdrawnHead and Neck Squamous Cell Carcinoma | HNSCC | Squamous Cell Carcinoma of the Larynx | Squamous Cell Carcinoma of the Oral Cavity | Squamous Cell Carcinoma of Hypopharynx
-
Regeneron PharmaceuticalsSanofiRecruitingCutaneous Squamous Cell CarcinomaUnited States, Australia, Spain, Germany, Belgium, Italy, France, Japan, United Kingdom, Brazil, Canada, Greece, Ireland, New Zealand, Poland, Russian Federation
-
Regeneron PharmaceuticalsCompletedAdvanced Cutaneous Squamous Cell CarcinomaUnited States, Spain, France, Italy, Australia, Germany, Brazil, Greece
-
Regeneron PharmaceuticalsSanofiCompletedCarcinoma, Basal CellUnited States, Canada, France, Italy, Spain, Germany, Belgium, Austria, Greece, Switzerland
-
Regeneron PharmaceuticalsActive, not recruitingBasal Cell Carcinoma | Cutaneous Squamous Cell CarcinomaUnited States, Puerto Rico
-
Regeneron PharmaceuticalsSanofiCompletedMelanomaKorea, Republic of, Serbia, Netherlands, United Kingdom
-
Regeneron PharmaceuticalsSanofiCompletedRecurrent Squamous Cell Carcinoma of Head | Recurrent Squamous Cell Carcinoma of Neck | Metastatic Squamous Cell Carcinoma of Head | Metastatic Squamous Cell Carcinoma NeckKorea, Republic of, United Kingdom
-
Regeneron PharmaceuticalsActive, not recruitingSquamous Cell Carcinoma of Head and NeckSpain, United States
-
Regeneron PharmaceuticalsWithdrawn
-
Palleon Pharmaceuticals, Inc.Active, not recruitingMelanoma | Cancer | Breast Cancer | Head and Neck Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | NSCLC | Non Small Cell Lung Cancer | Bladder Cancer | Colon Cancer | Urothelial Cancer | Oncology | CRC | Esophagogastric Junction Cancer | EGJUnited States
-
Regeneron PharmaceuticalsSanofiCompletedMalignanciesUnited States, Korea, Republic of, Australia, Ireland, United Kingdom
-
National Institute of Allergy and Infectious Diseases...Regeneron PharmaceuticalsWithdrawnHepatitis B VirusUnited States, Thailand, Canada, Brazil
-
Regeneron PharmaceuticalsBioNTech SERecruitingAdvanced Non-Small Cell Lung CancerUnited States, Korea, Republic of, Spain, Georgia, Taiwan, Turkey, Germany
-
Regeneron PharmaceuticalsRecruitingAdvanced Solid Tumor | Metastatic Solid TumorNetherlands
-
Regeneron PharmaceuticalsISA Pharmaceuticals B.V.Active, not recruitingCervical CancerSpain, Korea, Republic of, Netherlands, Brazil, Belgium, United States, Italy, Russian Federation
-
Regeneron PharmaceuticalsRecruitingRelapsed/Refractory Aggressive B-Cell LymphomaSpain, Poland, United States, Israel, Germany, Austria
-
SanofiCompletedMalignant Solid TumorItaly, Spain, Korea, Republic of, Belgium, France, Netherlands, United States, Taiwan, United Kingdom, Canada, Australia, Estonia, Germany
-
Regeneron PharmaceuticalsSanofiRecruitingHepatocellular Carcinoma | Non-small Cell Lung Cancer | Head and Neck Squamous Cell CarcinomaUnited States
-
Regeneron PharmaceuticalsRecruitingAdvanced Non-Small Cell Lung CancerKorea, Republic of, Taiwan, United States, Israel, Malaysia, Australia, Turkey, Georgia, Canada, Thailand
-
Regeneron PharmaceuticalsRecruitingOvarian Cancer | Fallopian Tube Cancer | Endometrial Cancer | Primary Peritoneal CancerUnited States, France, Spain, Belgium
-
Peter MacCallum Cancer Centre, AustraliaSanofi; Regeneron Pharmaceuticals; Monash University; University of Adelaide; University...Active, not recruitingNeoplasms | Cutaneous Squamous Cell Carcinoma of the Head and Neck | Non-melanoma Skin Cancer | Cutaneous Squamous Cell CarcinomaAustralia
-
Regeneron PharmaceuticalsRecruitingRecurrent Endometrial Cancer | Recurrent Ovarian Cancer | Recurrent Fallopian Tube Cancer | Recurrent Primary Peritoneal CancerUnited States, Israel, Spain, France, Italy, Korea, Republic of, United Kingdom, Netherlands, Belgium, Australia
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingStage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 | Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 | Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck | Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck | Stage...United States
-
Regeneron PharmaceuticalsSanofiCompletedSquamous Cell Carcinoma (SCC) | Recurrent or Metastatic, Platinum-refractory Cervical CancerSpain, Korea, Republic of, United States, United Kingdom, Taiwan, Brazil, Belgium, Australia, Italy, Canada, Japan, Greece, Poland, Russian Federation
-
SanofiBioNTech RNA Pharmaceuticals GmbHTerminatedMetastatic NeoplasmFrance, Spain, United States, Belgium, Germany, Netherlands
-
Regeneron PharmaceuticalsNot yet recruitingHead and Neck Squamous Cell Carcinoma (HNSCC)
-
SanofiTerminatedProstate Cancer | Non-small Cell Lung CancerTaiwan, United States, France, Italy, United Kingdom
-
Regeneron PharmaceuticalsRecruitingMetastatic Castration-resistant Prostate CancerUnited States
-
SanofiCompletedPlasma Cell MyelomaFrance, Italy, Czechia, Greece, Spain, Canada, Australia, United States, Brazil, Hungary
-
SanofiTerminatedLymphomaKorea, Republic of, Portugal, France, Taiwan, Italy, Netherlands, Spain
-
Regeneron PharmaceuticalsSanofiWithdrawn
-
University of Southern CaliforniaNational Cancer Institute (NCI)RecruitingRecurrent Skin Squamous Cell Carcinoma | Resectable Skin Squamous Cell Carcinoma | Stage I Skin Cancer | Stage II Skin Cancer | Stage III Skin CancerUnited States
-
Regeneron PharmaceuticalsActive, not recruitingAdvanced Non-small Cell Lung CancerUnited States
-
Alaunos TherapeuticsCompleted
-
Regeneron PharmaceuticalsRecruiting
-
Regeneron PharmaceuticalsTerminatedNon-Small Cell Lung Cancer | Triple Negative Breast Cancer | Merkel Cell Carcinoma | Basal Cell Carcinoma | Oropharynx Squamous Cell Carcinoma | Cutaneous Squamous Cell CarcinomaUnited States, Australia
-
Regeneron PharmaceuticalsPacific Pediatric Neuro-Oncology ConsortiumTerminatedHigh Grade Glioma | Diffuse Intrinsic Pontine Glioma | Relapsed Solid Tumor | Refractory Solid Tumor | Relapsed Central Nervous System Tumor | Refractory Central Nervous System TumorUnited States
-
Inovio PharmaceuticalsActive, not recruiting